Nearly 50 years of pulse-processing heritage. Three facilities across North America. Premium lentils, peas and plant proteins exported to more than 35 countries, feeding people and pets around the world.
✦ Cleaning up the balance sheet: $45M of recorded obligations to be settled →
Q2 2026 extends the momentum: revenue back to year-over-year growth, gross profit up 74%, and cash building, all in the Company's seasonally slowest half.
Revenue growth to $11.04M from $9.73M in Q2 2025, a return to year-over-year growth.
Gross profit of $1.62M, up from $926,825, with margin expanding to 14.6% from 9.5%.
Positive operating cash flow in the first half of 2026.
Cash at quarter end, up from $5.99M at March 31, 2026.
See the Q2 2026 news release and the interim filings on SEDAR+ for complete results.
Founded in 1978 and 100% owned by Eat Well Group, Belle Pulses transforms yellow and green peas into clean-label whole foods and functional ingredients trusted by global food brands.
A leading agribusiness platform capturing the value chain from farm to market, anchored by 3,000+ farmer relationships in a politically stable, geographically advantaged region.
Demonstrated scale and distribution across 35+ countries, serving world-class B2B customers including Nestlé, General Mills and Ingredion.
Positioned in the $449B food-ingredients market and heavily indexed to its fastest-growing segment: plant protein, projected to reach $162B by 2030.
Pulses are shelf-stable, water-efficient and soil-enriching, directly in the path of government policy momentum on both sides of the border, including billions earmarked for sustainable agriculture.
A leadership team of proven operators who conceived, built and sold Verdient Foods to Ingredion (NYSE: INGR), and have helped raise over $250M across ag, wellness and CPG.
Insiders, management and employees hold 49.4% of the company on a fully diluted basis. When shareholders win, we win.
Our ambition is straightforward: take Belle's winning model and replicate it at scale, becoming the number-one pulse processor in North America.
Three high-capacity facilities, each with expansion-ready land to scale production.
Active expansion into Europe, Asia and South America to meet rising international demand.
Decades of proprietary seed genetics, trade secrets and processing IP, a moat that commands premium pricing.
Category-leading innovation across human and pet food, unlocking premium product lines.
High-impact acquisitions at sector inflection points: scalable platforms with resilient margins.
The NPI obligation discharged in full for 5,000,000 shares, removing 65 million shares of potential dilution, and accrued compensation settled at 10 cents on the dollar.
Read the release → August 25, 2026Gross profit up 74%, gross margin climbs to 14.6% from 9.5%, and revenue returns to growth in the seasonally slowest half.
Read the release → August 5, 2026CEO Daniel Brody's first letter to shareholders: the protein tailwind, the capacity opportunity, and the four metrics he manages to.
Read the letter →Join Eat Well's investor mailing list for financial results, regulatory milestones and operational updates, straight from the company.